MYC and neoplasm: This leads to mobilization of intracellular calcium [43], concurrent induction of cyclin-dependent kinase inhibitor p21WAF1[44], [45] and subsequent degradation of key downstream effectors such as β-catenin and Myc in various tumor xenografts [40].